SKSammy Kimoloi

Sammy Kimoloi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sammy Kimoloi has a total of 54 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Association between blood group, CD4, Viral load and opportunistic infections among patients attending Kericho county referral comprehensive care clinic, Kenya

    by Lucy Cherono Korir, Tom Were, Barasa Mustafa, Sammy Kimoloi

    Erythrocyte antigens bringing about blood groups are considered pathogen receptor sites, including Human Immunodeficiency Virus (HIV), affecting approximately 39.9 million people worldwide, with 3.31% and 3.3% prevalence in Kenya and Kericho County, respectively. Limited studies showing inconsistent results and unpublished perceptions suggest a possible role of blood groups in Human Immunodeficiency Virus disease surveilled by changes in CD4 counts, viral load and opportunistic infections among infected. This study determined the ABO-Rhesus blood group distribution and association with CD4 counts, viral load and opportunistic infections at the Kericho County Referral Hospital Comprehensive Care Clinic in the year 2020. This cross-sectional, retrospective study comprised randomly sampled adults (≥18 years) without bone marrow transplant or transfusion history, with the sample size (n=285) calculated using the Yamane Taro formula. ABO-Rhesus typing was done on venous ethylenediaminetetraacetic acid blood using commercial antisera. Viral load and CD4 counts, determined using Abbott m2000sp/rt and FacsCalibur, respectively, and opportunistic infection data were documented in the data extraction form. Statistical Package for Social Sciences SPSS® version 26 was used to analyse and summarise data as means, standard deviation and prevalence ratios. Z-test, analysis of variance, regression, and chi-square were used to contrast, compare means, assess outcomes among variables, and determine relationships, respectively. Ethical principles were observed during specimens’ and participants’ information handling. Females were the majority, 174 (61.1%), and the mean age was 42.8 (12.8) years. Blood group O was most prevalent at 138 (48.4%), followed by A at 78 (27.4%), B at 59 (20.7%), and the least was AB. The Analysis of Variance showed a statistically non-significant association between blood groups on both viral load (p=0.74) and CD4 counts (p=0.84). Predictors for viral load change on regression analysis found increased viral load improvement in blood group AB-positive compared to blood group A-positive (OR=6.77, 95% CI [1.82-14.33], p=0.01). Most of the participants did not develop opportunistic infections, n=209 (73.3%). Tuberculosis was more prevalent among blood groups on chi-square: A-positive (16.2%), B-positive (16.4%), O-positive (17.7%), O-negative (12.5%) and B-negative. Blood groups A-negative and AB-negative developed no opportunistic infections. The differences were, however, not significant at the 95% level of significance (p=0.91). The study showed a non-significant association between the ABO blood groups and HIV infection based on CD4 counts, viral load and opportunistic infections. However, group AB-positive and those with good adherence were associated with viral load improvement. Increased CD4 count and body mass index were associated with reduced opportunistic infections. Viral load increase was associated with likelihood of opportunistic infection. Further studies need to be conducted for comparison.


  • Nest ecology, architecture, and behaviour of the stingless bee ( Meliponula beccarii ) in Baringo County, Kenya

    by Timothy Bett, Sabella J. Kiprono, Jane Macharia, Kipyegon John Kochey, Humphrey Agevi, Bartholomew N. Ondigo, Gladys J. Mengich, Sammy Kimoloi


  • Open Access

    Phytochemical composition and antimicrobial properties of stingless bee products from the East African Region

    by Christine Chepkemoi, Sabella J. Kiprono, Sammy Kimoloi

    Stingless bees (Apidae: Meliponini) are widely distributed across tropical and subtropical regions, including East Africa, where they produce honey, propolis, and pollen that have long been valued for their medicinal and nutritional properties. Specifically, the honey is recognized for its antimicrobial, antioxidant, and anti-inflammatory effects due to its rich content of bioactive compounds such as flavonoids, phenolics, and terpenoids. In East African countries, there has been an increasing interest in the antimicrobial properties and phytochemical composition of stingless bee products to validate their traditional uses and explore their therapeutic potential. This narrative review highlights the findings of these studies, which have mainly focused on the honey of Meliponula, Plebeina, Hypotrigona, and Dactylurina species. The honey of these species has particularly been reported to be active against several common bacterial pathogens, including Escherichia coli, Staphylococcus aureus, methicillin-resistant Staphylococcus aureus (MRSA), Haemophilus influenzae, Bacillus subtilis, Enterococcus faecalis, Klebsiella pneumoniae, Listeria monocytogenes, Pseudomonas aeruginosa, and Salmonella typhi. Moreover, reports also indicate that honey and propolis of some East African stingless bees are active against Candida albicans and Aspergillus niger. Reports on phytochemical analyses indicate that depending on the region, stingless bee honey from the East African region contains diverse phytochemical contents, including flavonoids, phenols, tannins, saponins, alkaloids, glycosides, steroids, and triterpenoids. These findings suggest that stingless bee honey possesses significant potential as a natural source of antimicrobial agents and functional food. However, variations in phytochemical composition influenced by species diversity and environmental conditions indicate the need for further research. Future studies should prioritize standardization, detailed phytochemical profiling, and clinical validation, alongside sustainable meliponiculture development. Unlike the honey, however, there are limited studies on the other nest products (pollen, cerumen, and propolis). This calls for more research, particularly on propolis and pollen, which are known to have antimicrobial properties. There is also a need for isolation of pure antimicrobial compounds from the nest’s products and subsequent mechanistic studies. Future studies should also expand the antimicrobial studies to include viruses, fungi, and protozoans.

  • Open Access

    Comparative Analysis of Anti-inflammatory, Analgesic, and Antioxidant Properties of Fagaropsis hildebrandtii and Fagaropsis angolensis Extracts

    by Peter Maloba, Sammy Kimoloi, Jared Onyancha

    Fagaropsis hildebrandtii and Fagaropsis angolensis are widely used across East, Central, and Southern parts of Africa as traditional remedies for the management of various disorders associated with inflammation, pain, and oxidative stress. However, it remains unclear whether F. hildebrandtii and F. angolensis plant parts have equivalent efficacy. Therefore, the objective of this study was to compare the anti-inflammatory, analgesic, and antioxidant properties of the two medicinal plants. This was an experimental controlled research design. The study area was Embu and Makueni Counties. Methanol and water extracts of powdered F. hildebrandtii stem bark and F. angolensis leaves were prepared by maceration. Different extract concentrations were then tested for anti-inflammatory, analgesic, and antioxidant activity using the carrageenan-induced paw edema model, acetic acid-induced writhing model, and 2,2-Diphenyl-1-picrylhydrazyl (DPPH) free radical assay, respectively. Comparative analysis revealed that F. hildebrandtii stem bark extract had higher anti-inflammatory activity compared to F. angolensis leaves (P < 0.05). However, F. angolensis leaves exhibited significantly greater analgesic activity than F. hildebrandtii stem bark extracts (P < 0.05). Comparison of antioxidant activities of the extracts did not show any significant differences (P > 0.05). In conclusion, the findings indicate variation in analgesic and anti-inflammatory properties, but not in the antioxidant properties of F. hildebrandtii and F. angolensis. The study recommends plant preservation, active pharmaceutical ingredient identification, testing in non-human primates, and in clinical trials.

  • Stingless bee honey: Nutraceutical properties and urgent call for proposed global standards

    by Patricia Vit, Bajaree Chuttong, Elia Ramírez-Arriaga, Eunice Enríquez, Zhengwei Wang, Cleofas Cervancia, Favio Vossler, Sammy Kimoloi, Michael S. Engel, Ricardo R. Contreras, et al.


  • Open Access

    Hematological Changes in Newly Diagnosed Pulmonary Tuberculosis Patients on Standard Anti-TB Treatment Regimen and their Influence on Smear Conversion

    by Edwin Mwilitsa, Evans Raballah, Sammy Kimoloi

    Pulmonary tuberculosis (PTB) mortality remains high despite the availability of effective anti-TB therapy. Disease and treatment-associated hematological derangements at diagnosis and during therapy might contribute to this high TB mortality rate. This paper aims to determine hematological changes in newly diagnosed pulmonary tuberculosis patients on standard anti-TB treatment regimen and their influence on smear conversion. The study adopted a longitudinal design in which 55 newly diagnosed HIV negative PTB patients were followed up to the fifth month of anti-TB therapy. Blood samples (5ml) were collected for diagnosis during the second and fifth months and analyzed using automated HumaCount 5D hematology analyzer. Data was analyzed using Kruskal-wallis test with Dunn’s multiple comparisons test in Graph-Pad prism version 6.0. Throughout therapy, there was a statistically significant time-dependent decrease in median total white blood cell counts from 6.82x103/ uL at diagnosis to 5.87x103/ uL at the fifth month (P=0.0358). This decrease in total WBC count was majorly driven by significant decrease in the neutrophil numbers from 4.31x103/ uL at diagnosis to 2.97x103/ uL at the fifth month. The proportion of patients who had anemia at the fifth month of treatment increased compared to the second month post intensive phase. There was also a significant decrease in MCV, MCH and MCHC at the second month compared to diagnosis. Moreover, the median platelet count, MPV, PDW and PCT% decreased from 314x103/ uL, 8.9 fL, 10.4 fL and 0.273 at diagnosis to 232x103/ uL, 10.15 fL, 12.5 fL and 0.235 at the fifth month, respectively. High WBC count, high platelet count, low lymphocyte count and low HGB at the end of month two of therapy were shown to increase the likelihood of sputum non-conversion (OR-2.42 (95% Ci 2.07-2.82)), (OR-1.5 (95% Ci 1.01-2.22)), (OR-1 (95% Ci 1-1)) and (OR-2.58 (95% Ci 1.68-3.95)), respectively (P<0.05). A significant number of PTB patients presented with anemia, thrombocytosis and leukocytosis. The proportion of patients with anemia increased over time. The study recommends screening for hematological abnormalities in patients for tailored patient interventions for better clinical outcomes.

  • In-vitro Antimicrobial Effects and Phytochemical Contents of Stingless Bee Meliponula beccarii Honey and Pollen from Baringo County, Kenya

    by Christine Chepkemoi, Timothy K Bett, Elias Mandela, Sabella Kiprono, Jared Onyancha, Sammy Kimoloi

    Background: Afro-tropical stingless bees produce several products including honey, propolis, cerumen and pollen, which are widely used as traditional medicine and food. In Baringo County, Kenya stingless bee honey in particular is widely used as a traditional remedy for respiratory disorders, stomach disorders and oral thrush, commonly associated with bacterial and fungal infections. However, scientific data on the antimicrobial activities and phytochemical content of stingless bee products from Baringo is scarce. Objectives: The objective of this study was to investigate the in vitro antimicrobial activities and phytochemical content of Meliponula beccarii stingless bee honey and pollen from Baringo County. Materials and methods: Eleven honey and pollen samples were conveniently sampled from eleven wild occurring stingless bee nests in three ecologically distinct areas. Increasing concentrations of honey and pollen samples were then prepared and tested against H. influenzae, E. coli, MRSA and C. albicans using agar well diffusion assay. The broth microdilution test was further performed to determine the Minimum Inhibitory Concentrations (MICs) and Minimum Bactericidal Concentrations (MBCs). Standard qualitative methods were used to analyse the phytochemical contents of the honey and pollen samples. Data was analysed by two-way ANOVA and Tukey’s post-hoc tests. Results: in comparison to distilled water (negative control), the honey samples had a significantly higher mean zones of inhibition at concentration of 100% v/v against E. coli (9.0±4.7 mm vs 0 mm, p<0.0001, N=11), H. influenzae (11.1±5.0 mm vs 0 mm, p0.0001, N=11). However, compared to ciprofloxacin standard (30ug/ml), all the concentrations of honey samples had significantly lower mean zones of inhibition against H. influenzae (8.8±2.4 mm vs 25±0.58 mm, p<0.0001, N=11), E. coli (5.7±3.4 mm vs 31.7±1.5 mm, p<0.0001, N=11) and MRSA (8.1±2.8 mm vs 27±0 mm). All the honey samples did not exhibit activity against C. albicans even at 100% (v/v). The mean MICs against E. coli, H. influenzae and MRSA were 9.38% (v/v), 18.75% (v/v) and 18.75% (v/v), respectively. Notably, the honey samples exhibited bactericidal activity, only against MRSA with a mean MBC of 60.94% (v/v). All the pollen samples showed no antibacterial and antifungal activities against the tested micro-organisms. Qualitative analyses revealed that the honey and pollen samples of Meliponula beccarii contain alkaloids, phenolics, triterpenoids, flavonoids, saponins, tannins, glycosides and steroids, but not terpenoids. Conclusion: Some but not all Meliponula beccarii honey samples from Baringo County has antibacterial activities. The honey and pollen are rich in various phytochemical compounds. Our findings validate the use of Meliponula beccarii honey in traditional treatment of bacterial infections and its further investigation as a potential source of novel agents against drug resistant pathogenic bacteria.


  • Protective effect of Spirulina platensis extract on aflatoxin B1 immunotoxicities in mice

    by Masese Johnson, Kipkoech Gilbert, Kimoloi Sammy, Mwitari Peter, Nguka Gordon, Mutai Charles

    Aspergillus flavus and Aspergillus parasiticus are the main Aspergillums species that form aflatoxins. Aflatoxins are hepatotoxic, teratogenic, carcinogenic and immunosuppressive. This study aimed to assess Spirulina platensis (S. platensis) extract inhibitory effect against aflatoxin B1 (AFB1) induced immunotoxicity in male Swiss albino mice. Twenty-five inbred weaned mice were randomly divided into five groups. Group I (Control group), were given routine diet. Treatments administered were: Group II (S. platensis extract 100 mg/kg/day), Group III (AFB1 200 µg/kg/day), Group IV (S. platensis extract 100 mg/kg/day and AFB1 200 µg/kg/day) and Group V (S. platensis extract 200 mg/kg/day and AFB1 200 µg/kg/day) for 28 consecutive days. Blood was aseptically collected and centrifuged to obtain serum. Quantitative determination of IgG, IgM and IgA in blood serum was done using ELIZA kits. One-way ANOVA data analysis was done. Post-hoc analysis was done using Tukey’s Honestly Significantly Differenced (HSD). P<0.05 statistical significance level was considered significant. Compared to group I (control), treatment with AFB1 200 µg/Kg/day (group III) led to reduced IgA (0.7147±0.001 vs. 0.7075±0.010); reduced IgM (0.0916±0.003 vs. 0.0866±0.019) and elevated IgG (0.1746±0.001 vs. 0.2808±0.243) mean levels. Supplementation of S. platensis extract 200 mg/Kg/day (group V) reversed the AFB1 (200 µg/kg/day)-induced depression of IgA levels (0.7124±0.005 vs. 0.7075±0.010; P=0.05437); IgM (0.1005±0.004 vs. 0.0866±0.019; P=0.0178); as well as the induced elevation of IgG levels (0.1749±0.001 vs. 0.2808±0.243; P=0.0155). In conclusion, immune changes in IgG and IgM caused by AFB1 could be reversed by supplementation of S. platensis extract.


  • Open Access

    Therapeutic uses of stingless bee honey by traditional medicine practitioners in Baringo County, Kenya

    by J. Kiprono Sabella, Mengich Gladys, N. Ondigo Bartholomew, Mutai Charles, Kimoloi Sammy

    African traditional medicine knowledge, skills and practices have often been passed verbally from the older generation to the younger generation. However, the current traditional medicine practitioners (TMPs) are rapidly aging, while the younger generation is not taking up the practice. Therefore, this study aimed at documenting the therapeutic uses of stingless bee honey among TMPs in Baringo County. Briefly, 91 TMPs were conveniently sampled and interviewed using an interviewer-administered questionnaire specifically designed to capture source of traditional medicine knowledge and skills, traditional therapeutic uses of stingless bee honey, duration of therapy and associated side effects. All the 91 TMPs knew about stingless bee honey and used it as a traditional medicinal product to treat various health-related disorders. Respiratory disorders, stomach disorders, oral thrush, wounds, measles and poisoning, were the five top-most common disorders that were commonly treated using stingless bee honey by the TMPs. The honey is also used to treat cancer, allergies and pain. The majority of the TMPs (72.34%) reported that the honey was not associated with side effects and all of them said that it was a highly effective form of traditional therapy. Duration of therapy ranged from 1-5 days (39.77%), 6-10 days (11.36%), 11-15 days (9.09%), >15 days (3.41%) until when the health condition improved. In conclusion, stingless bee honey is widely used as a traditional medicine to treat various disorders by TMPs in Baringo county. There is need for future detailed pharmacological studies on the stingless bee honey from the study area. Key words: stingless bee honey, therapeutic uses, therapy duration, respiratory disorders, gastrointestinal disorders African traditional medicine knowledge, skills and practices have often been passed verbally from the older generation to the younger generation. However, the current traditional medicine practitioners (TMPs) are rapidly aging, while the younger generation is not taking up the practice. Therefore, this study aimed at documenting the therapeutic uses of stingless bee honey among TMPs in Baringo County. Briefly, 91 TMPs were conveniently sampled and interviewed using an interviewer-administered questionnaire specifically designed to capture source of traditional medicine knowledge and skills, traditional therapeutic uses of stingless bee honey, duration of therapy and associated side effects. All the 91 TMPs knew about stingless bee honey and used it as a traditional medicinal product to treat various health-related disorders. Respiratory disorders, stomach disorders, oral thrush, wounds, measles and poisoning, were the five top-most common disorders that were commonly treated using stingless bee honey by the TMPs. The honey is also used to treat cancer, allergies and pain. The majority of the TMPs (72.34%) reported that the honey was not associated with side effects and all of them said that it was a highly effective form of traditional therapy. Duration of therapy ranged from 1-5 days (39.77%), 6-10 days (11.36%), 11-15 days (9.09%), >15 days (3.41%) until when the health condition improved. In conclusion, stingless bee honey is widely used as a traditional medicine to treat various disorders by TMPs in Baringo county. There is need for future detailed pharmacological studies on the stingless bee honey from the study area. Key words: stingless bee honey, therapeutic uses, therapy duration, respiratory disorders, gastrointestinal disorders